Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...
Сохранить в:
Главные авторы: | , , , , , |
---|---|
Формат: | Artigo |
Язык: | английский |
Опубликовано: |
2020
|
Online-ссылка: | https://doi.org/10.3389/fcell.2020.596679 https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|